From the Glaxo Laboratories, Greenford
Twenty cases of gynaecomastia among 38 men engaged in the manufacture of stilboestrol are described and the manner in which control of this industrial hazard was achieved. The account is based solely on clinical examination of the breasts, except in three cases where histological reports were obtained.
In February 1940, some of the men working on the stilboestrol plant noticed that their breasts were becoming enlarged. Therefore all those who had been exposed to stilboestrol at any stage of research or manufacture were examined, and in most, swellings in the mammary area were found. Later, work with dienoestrol also caused symptoms in one research chemist. This established that there was an occupational risk in the manufacture of all oestrogens.
While it was known that the administration of large amounts of oestrogens caused overgrowth of the fibrous supporting tissue of the breast, it had not been realized that small amounts of stilboestrol, absorbed during manufacture under apparently good conditions, could cause such marked physical signs. Dunn (1940) reported gynaecomastia and diminution of sexual function after a course of 5 mg. stilboestrol daily by the mouth for about two months, and since then references have been made in the medical journals to enlargement of the breast during the course of stilboestrol therapy for prostatic cancer.
The first twelve cases, two of which were described by Scarff and Smith (1942) He left in April and wrote at the end of June that he had developed a lump in his breast and was going to be operated on. Reports sent to me later by the doctor said that on July 2nd a local excision of the left breast was performed for mastitis, and the section showed a simple fibro-adenoma with no evidence of malignancy; that in September the wound was soundly healed and that there was no sign of inflammation. January, 1941: he came to see me and told me that he had noticed nothing wrong until June, 1940; the left breast then became sore, tender and visibly swollen; he could feel a hard lump in the centre of the swelling about tne size and shape of a florin. No symptoms or signs.
Case 13.* January 1st. 1941: aet. 23. Production 3 months, but had not been exposed to any of the oestrogenic stages of manufacture until an accident on December 20th, 1940, when he had been splashed with a resinous, sticky mixture containing stilboestrol which was removed from his skin with great difficulty. Three days later he had pain and tenderness in both breasts.
In each breast there is a hard nodule, 1-inch diameter. 
